CompletedNCT01395992
Long-Term Asenapine Safety After Treatment for Bipolarity
About this title
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
Read the official source — NCT01395992Researchers studied asenapine, tracking side effects to assess long-term safety in people with bipolarity type I.
Medication studyAges 18+United States
Understand this study
What did researchers investigate?
Researchers studied asenapine, tracking side effects to assess long-term safety in people with bipolarity type I.
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- AustinSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateApril 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 165
- Sponsor
- Forest Laboratories
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT01395992
- Official title
Show the full official title
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Austin
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied asenapine, tracking side effects to assess long-term safety in people with bipolarity type I.
Who is behind this study?
The study sponsor is Forest Laboratories, a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including asenapine.
Who was this study for?
Listed age limits: from 18 years.
